FcγRIIB: a modulator of cell activation and humoral tolerance

References

• Hogarth PM. Fc receptors are major mediators of antibody based inflammation in autoimmunity. Curr. Opin. Immunol.14(6), 798–802 (2002).
   PubMed Web of Science ®Google Scholar
• Nimmerjahn F, Ravetch JV. Fcgamma receptors as regulators of immune responses. Nat. Rev. Immunol.8(1), 34–47 (2008).
   PubMed Web of Science ®Google Scholar
• Takai T. Roles of Fc receptors in autoimmunity. Nat. Rev. Immunol.2(8), 580–592 (2002).
   PubMed Web of Science ®Google Scholar
• Tarasenko T, Dean JA, Bolland S. FcgammaRIIB as a modulator of autoimmune disease susceptibility. Autoimmunity40(6), 409–417 (2007).
   PubMed Web of Science ®Google Scholar
• Daeron M, Lesourne R. Negative signaling in Fc receptor complexes. Adv. Immunol.89, 39–86 (2006).
   PubMed Web of Science ®Google Scholar
• Nitschke L, Floyd H, Crocker PR. New functions for the sialic acid-binding adhesion molecule CD22, a member of the growing family of Siglecs. Scand. J. Immunol.53(3), 227–234 (2001).
   PubMedGoogle Scholar
• Ravetch JV, Lanier LL. Immune inhibitory receptors. Science290(5489), 84–89 (2000).
   PubMed Web of Science ®Google Scholar
• Nimmerjahn F, Ravetch JV. Antibody-mediated modulation of immune responses. Immunol. Rev.236, 265–275 (2010).
   PubMed Web of Science ®Google Scholar
• Baerenwaldt A, Nimmerjahn F. Immune regulation: FcgammaRIIB – regulating the balance between protective and autoreactive immune responses. Immunol. Cell. Biol.86(6), 482–484 (2008).
   PubMedGoogle Scholar
• Davis RS, Ehrhardt GR, Leu CM, Hirano M, Cooper MD. An extended family of Fc receptor relatives. Eur. J. Immunol.35(3), 674–680 (2005).
   PubMed Web of Science ®Google Scholar
• Foy TM, Lynch RG, Waldschmidt TJ. Ontogeny and distribution of the murine B cell Fc gamma RII. J. Immunol.149(5), 1516–1523 (1992).
   PubMedGoogle Scholar
• Xiang Z, Cutler AJ, Brownlie RJ et al. FcgammaRIIb controls bone marrow plasma cell persistence and apoptosis. Nat. Immunol.8(4), 419–429 (2007).
   PubMed Web of Science ®Google Scholar
• Kato I, Takai T, Kudo A. The pre-B cell receptor signaling for apoptosis is negatively regulated by Fc gamma RIIB. J. Immunol.168(2), 629–634 (2002).
   PubMed Web of Science ®Google Scholar
• De Andres B, Mueller AL, Verbeek S, Sandor M, Lynch RG. A regulatory role for Fcgamma receptors CD16 and CD32 in the development of murine B cells. Blood92(8), 2823–2829 (1998).
   PubMedGoogle Scholar
• Baerenwaldt A, Lux A, Danzer H et al. Fcgamma receptor IIB (FcgammaRIIB) maintains humoral tolerance in the human immune system in vivo. Proc. Natl Acad. Sci. USA108(46), 18772–18777 (2011).
   PubMed Web of Science ®Google Scholar
• Macardle PJ, Mardell C, Bailey S et al. FcgammaRIIb expression on human germinal center B lymphocytes. Eur. J. Immunol.32(12), 3736–3744 (2002).
   PubMedGoogle Scholar
• Xiu Y, Nakamura K, Abe M et al. Transcriptional regulation of Fcgr2b gene by polymorphic promoter region and its contribution to humoral immune responses. J. Immunol.169(8), 4340–4346 (2002).
   PubMed Web of Science ®Google Scholar
• Rahman ZS, Alabyev B, Manser T. FcgammaRIIB regulates autoreactive primary antibody-forming cell, but not germinal center B cell, activity. J. Immunol.178(2), 897–907 (2007).
   PubMedGoogle Scholar
• Rahman ZS, Manser T. Failed up-regulation of the inhibitory IgG Fc receptor Fc gamma RIIB on germinal center B cells in autoimmune-prone mice is not associated with deletion polymorphisms in the promoter region of the Fc gamma RIIB gene. J. Immunol.175(3), 1440–1449 (2005).
   PubMedGoogle Scholar
• Dhodapkar KM, Banerjee D, Connolly J et al. Selective blockade of the inhibitory Fcgamma receptor (FcgammaRIIB) in human dendritic cells and monocytes induces a type I interferon response program. J. Exp. Med.204(6), 1359–1369 (2007).
   PubMed Web of Science ®Google Scholar
• Dhodapkar KM, Kaufman JL, Ehlers M et al. Selective blockade of inhibitory Fcgamma receptor enables human dendritic cell maturation with IL-12p70 production and immunity to antibody-coated tumor cells. Proc. Natl Acad. Sci. USA102(8), 2910–2915 (2005).
   PubMed Web of Science ®Google Scholar
• Dhodapkar KM, Krasovsky J, Williamson B, Dhodapkar MV. Antitumor monoclonal antibodies enhance cross-presentation of Cellular antigens and the generation of myeloma-specific killer T cells by dendritic cells. J. Exp. Med.195(1), 125–133 (2002).
   PubMed Web of Science ®Google Scholar
• Boruchov AM, Heller G, Veri MC, Bonvini E, Ravetch JV, Young JW. Activating and inhibitory IgG Fc receptors on human DCs mediate opposing functions. J. Clin. Invest.115(10), 2914–2923 (2005).
   PubMed Web of Science ®Google Scholar
• Devaraj S, Davis B, Simon SI, Jialal I. CRP promotes monocyte-endothelial cell adhesion via Fcgamma receptors in human aortic endothelial cells under static and shear flow conditions. Am. J. Physiol. Heart Circ. Physiol.1(3), 1170–1176 (2006).
   Google Scholar
• Qin D, Wu J, Vora KA et al. Fc gamma receptor IIB on follicular dendritic cells regulates the B cell recall response. J. Immunol.164(12), 6268–6275 (2000).
   PubMedGoogle Scholar
• Phillips NE, Parker DC. Cross-linking of B lymphocyte Fc gamma receptors and membrane immunoglobulin inhibits anti-immunoglobulin-induced blastogenesis. J. Immunol.132(2), 627–632 (1984).
   PubMed Web of Science ®Google Scholar
• Ono M, Bolland S, Tempst P, Ravetch JV. Role of the inositol phosphatase SHIP in negative regulation of the immune system by the receptor Fc(gamma)RIIB. Nature383(6597), 263–266 (1996).
   PubMed Web of Science ®Google Scholar
• Ono M, Okada H, Bolland S et al. Deletion of SHIP or SHP-1 reveals two distinct pathways for inhibitory signaling. Cell90(2), 293–301 (1997).
   PubMed Web of Science ®Google Scholar
• Pearse RN, Kawabe T, Bolland S, Guinamard R, Kurosaki T, Ravetch JV. SHIP recruitment attenuates Fc gamma RIIB-induced B cell apoptosis. Immunity10(6), 753–760 (1999).
   PubMed Web of Science ®Google Scholar
• Tzeng SJ, Bolland S, Inabe K, Kurosaki T, Pierce SK. The B cell inhibitory Fc receptor triggers apoptosis by a novel c-Abl-family kinase dependent pathway. J. Biol. Chem.280(42), 35247-35254 (2005).
   PubMedGoogle Scholar
• Radbruch A, Muehlinghaus G, Luger EO et al. Competence and competition: the challenge of becoming a long-lived plasma cell. Nat. Rev. Immunol.6(10), 741–750 (2006).
   PubMed Web of Science ®Google Scholar
• Brauweiler AM, Cambier JC. Autonomous SHIP-dependent FcgammaR signaling in pre-B cells leads to inhibition of cell migration and induction of cell death. Immunol. Lett.92(1–2), 75–81 (2004).
   PubMedGoogle Scholar
• Fournier EM, Siberil S, Costes A et al. Activation of human peripheral IgM+ B cells is transiently inhibited by BCR-independent aggregation of Fc gammaRIIB. J. Immunol.181(8), 5350–5359 (2008).
   PubMed Web of Science ®Google Scholar
• Takai T, Ono M, Hikida M, Ohmori H, Ravetch JV. Augmented humoral and anaphylactic responses in Fc gamma RII-deficient mice. Nature379(6563), 346–349 (1996).
   PubMed Web of Science ®Google Scholar
• Bolland S, Ravetch JV. Spontaneous autoimmune disease in Fc(gamma)RIIB-deficient mice results from strain-specific epistasis. Immunity13(2), 277–228 (2000).
   PubMed Web of Science ®Google Scholar
• Bolland S, Yim YS, Tus K, Wakeland EK, Ravetch JV. Genetic modifiers of systemic lupus erythematosus in FcgammaRIIB(-/-) mice. J. Exp. Med.195(9), 1167–1174 (2002).
   PubMed Web of Science ®Google Scholar
• Yajima K, Nakamura A, Sugahara A, Takai T. FcgammaRIIB deficiency with Fas mutation is sufficient for the development of systemic autoimmune disease. Eur. J. Immunol.33(4), 1020–1029 (2003).
   PubMed Web of Science ®Google Scholar
• Pisitkun P, Deane JA, Difilippantonio MJ, Tarasenko T, Satterthwaite AB, Bolland S. Autoreactive B cell responses to RNA-related antigens due to TLR7 gene duplication. Science312(5780), 1669–1672 (2006).
   PubMed Web of Science ®Google Scholar
• Subramanian S, Tus K, Li QZ et al. A TLR7 translocation accelerates systemic autoimmunity in murine lupus. Proc. Natl Acad. Sci. USA103(26), 9970–9975 (2006).
   PubMed Web of Science ®Google Scholar
• Fukuyama H, Nimmerjahn F, Ravetch JV. The inhibitory Fcgamma receptor modulates autoimmunity by limiting the accumulation of immunoglobulin G+ anti-DNA plasma cells. Nat. Immunol.6(1), 99–106 (2005).
   PubMed Web of Science ®Google Scholar
• Paul E, Nelde A, Verschoor A, Carroll MC. Follicular exclusion of autoreactive B cells requires FcgammaRIIb. Int. Immunol.19(4), 365–373 (2007).
   PubMed Web of Science ®Google Scholar
• Tiller T, Kofer J, Kreschel C et al. Development of self-reactive germinal center B cells and plasma cells in autoimmune Fc gammaRIIB-deficient mice. J. Exp. Med.207(12), 2767–2778 (2010).
   PubMed Web of Science ®Google Scholar
• Mcgaha TL, Karlsson MC, Ravetch JV. FcgammaRIIB deficiency leads to autoimmunity and a defective response to apoptosis in Mrl-MpJ mice. J. Immunol.180(8), 5670–5679 (2008).
   PubMedGoogle Scholar
• Jiang Y, Hirose S, Abe M et al. Polymorphisms in IgG Fc receptor IIB regulatory regions associated with autoimmune susceptibility. Immunogenetics51(6), 429–435 (2000).
   PubMed Web of Science ®Google Scholar
• Jiang Y, Hirose S, Sanokawa-Akakura R et al. Genetically determined aberrant down-regulation of FcgammaRIIB1 in germinal center B cells associated with hyper-IgG and IgG autoantibodies in murine systemic lupus erythematosus. Int. Immunol.11(10), 1685–1691 (1999).
   PubMed Web of Science ®Google Scholar
• Pritchard NR, Cutler AJ, Uribe S, Chadban SJ, Morley BJ, Smith KG. Autoimmune-prone mice share a promoter haplotype associated with reduced expression and function of the Fc receptor FcgammaRII. Curr. Biol.10(4), 227–230 (2000).
   PubMed Web of Science ®Google Scholar
• Mcgaha TL, Sorrentino B, Ravetch JV. Restoration of tolerance in lupus by targeted inhibitory receptor expression. Science307(5709), 590–593 (2005).
   PubMed Web of Science ®Google Scholar
• Brownlie RJ, Lawlor KE, Niederer HA et al. Distinct cell-specific control of autoimmunity and infection by FcgammaRIIb. J. Exp. Med.205(4), 883–895 (2008).
   PubMedGoogle Scholar
• Lin Q, Xiu Y, Jiang Y et al. Genetic dissection of the effects of stimulatory and inhibitory IgG Fc receptors on murine lupus. J. Immunol.177(3), 1646–1654 (2006).
   PubMedGoogle Scholar
• Horton HM, Chu SY, Ortiz EC et al. Antibody-mediated coengagement of FcgammaRIIb and B cell receptor complex suppresses humoral immunity in systemic lupus erythematosus. J. Immunol.186(7), 4223–4233 (2011).
   PubMed Web of Science ®Google Scholar
• Veri MC, Burke S, Huang L et al. Therapeutic control of B cell activation via recruitment of Fcgamma receptor IIb (CD32B) inhibitory function with a novel bispecific antibody scaffold. Arthritis Rheum.62(7), 1933–1943 (2010).
   PubMed Web of Science ®Google Scholar
• Boross P, Arandhara VL, Martin-Ramirez J et al. The inhibiting Fc receptor for IgG, FcgammaRIIB, is a modifier of autoimmune susceptibility. J. Immunol.187(3), 1304–1313 (2011).
   PubMed Web of Science ®Google Scholar
• Bygrave AE, Rose KL, Cortes-Hernandez J et al. Spontaneous autoimmunity in 129 and C57BL/6 mice-implications for autoimmunity described in gene-targeted mice. PLoS Biol.2(8), E243 (2004).
   PubMed Web of Science ®Google Scholar
• Wandstrat AE, Nguyen C, Limaye N et al. Association of extensive polymorphisms in the SLAM/CD2 gene cluster with murine lupus. Immunity21(6), 769–780 (2004).
   PubMed Web of Science ®Google Scholar
• Bickerstaff MC, Botto M, Hutchinson WL et al. Serum amyloid P component controls chromatin degradation and prevents antinuclear autoimmunity. Nat. Med.5(6), 694–697 (1999).
   PubMed Web of Science ®Google Scholar
• Nitschke L, Carsetti R, Ocker B, Kohler G, Lamers MC. CD22 is a negative regulator of B-cell receptor signalling. Curr. Biol.7(2), 133–143 (1997).
   PubMed Web of Science ®Google Scholar
• O’keefe TL, Williams GT, Batista FD, Neuberger MS. Deficiency in CD22, a B cell-specific inhibitory receptor, is sufficient to predispose to development of high affinity autoantibodies. J. Exp. Med.189(8), 1307–1313 (1999).
   PubMed Web of Science ®Google Scholar
• Samardzic T, Marinkovic D, Danzer CP, Gerlach J, Nitschke L, Wirth T. Reduction of marginal zone B cells in CD22-deficient mice. Eur. J. Immunol.32(2), 561–567 (2002).
   PubMed Web of Science ®Google Scholar
• Lathrop SK, Bloom SM, Rao SM et al. Peripheral education of the immune system by colonic commensal microbiota. Nature478(7368), 250–254 (2011).
   PubMed Web of Science ®Google Scholar
• Kriegel MA, Sefik E, Hill JA, Wu HJ, Benoist C, Mathis D. Naturally transmitted segmented filamentous bacteria segregate with diabetes protection in nonobese diabetic mice. Proc. Natl Acad. Sci. USA108(28), 11548–11553 (2011).
   PubMed Web of Science ®Google Scholar
• Kranich J, Maslowski KM, Mackay CR. Commensal flora and the regulation of inflammatory and autoimmune responses. Semin. Immunol.23(2), 139–145 (2011).
   PubMed Web of Science ®Google Scholar
• Okazaki T, Otaka Y, Wang J et al. Hydronephrosis associated with antiurothelial and antinuclear autoantibodies in BALB/c-fcgr2b-/-Pdcd1-/- mice. J. Exp. Med.202(12), 1643–1648 (2005).
   PubMedGoogle Scholar
• Clynes R, Calvani N, Croker BP, Richards HB. Modulation of the immune response in pristane-induced lupus by expression of activation and inhibitory Fc receptors. Clin. Exp. Immunol.141(2), 230–237 (2005).
   PubMed Web of Science ®Google Scholar
• Nakamura A, Nukiwa T, Takai T. Deregulation of peripheral B-cell development in enhanced severity of collagen-induced arthritis in FcgammaRIIB-deficient mice. J. Autoimmun.20(3), 227–236 (2003).
   PubMedGoogle Scholar
• Nakamura A, Yuasa T, Ujike A et al. Fcgamma receptor IIB-deficient mice develop Goodpasture’s syndrome upon immunization with type IV collagen: a novel murine model for autoimmune glomerular basement membrane disease. J. Exp. Med.191(5), 899–906 (2000).
   PubMed Web of Science ®Google Scholar
• Waisberg M, Tarasenko T, Vickers BK et al. Genetic susceptibility to systemic lupus erythematosus protects against cerebral malaria in mice. Proc. Natl Acad. Sci. USA108(3), 1122–1127 (2011).
   PubMedGoogle Scholar
• Clatworthy MR, Willcocks L, Urban B et al. Systemic lupus erythematosus-associated defects in the inhibitory receptor FcgammaRIIb reduce susceptibility to malaria. Proc. Natl Acad. Sci. USA104(17), 7169–7174 (2007).
   PubMed Web of Science ®Google Scholar
• Willcocks LC, Carr EJ, Niederer HA et al. A defunctioning polymorphism in fcgr2b is associated with protection against malaria but susceptibility to systemic lupus erythematosus. Proc. Natl Acad. Sci. USA107(17), 7881–7885 (2010).
   PubMed Web of Science ®Google Scholar
• Steinman RM, Hawiger D, Liu K et al. Dendritic cell function in vivo during the steady state: a role in peripheral tolerance. Ann. NY Acad. Sci.987, 15–25 (2003).
   PubMed Web of Science ®Google Scholar
• Dudziak D, Kamphorst AO, Heidkamp GF et al. Differential antigen processing by dendritic cell subsets in vivo. Science315(5808), 107–111 (2007).
   PubMed Web of Science ®Google Scholar
• Hawiger D, Inaba K, Dorsett Y et al. Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo. J. Exp. Med.194(6), 769–779 (2001).
   PubMed Web of Science ®Google Scholar
• Yamazaki S, Dudziak D, Heidkamp GF et al. CD8+ CD205+ splenic dendritic cells are specialized to induce Foxp3+ regulatory T cells. J. Immunol.181(10), 6923–6933 (2008).
   PubMed Web of Science ®Google Scholar
• Rafiq K, Bergtold A, Clynes R. Immune complex-mediated antigen presentation induces tumor immunity. J. Clin. Invest.110(1), 71–79 (2002).
   PubMed Web of Science ®Google Scholar
• Regnault A, Lankar D, Lacabanne V et al. Fcgamma receptor-mediated induction of dendritic cell maturation and major histocompatibility complex class I-restricted antigen presentation after immune complex internalization. J. Exp. Med.189(2), 371–380 (1999).
   PubMed Web of Science ®Google Scholar
• Groh V, Li YQ, Cioca D et al. Efficient cross-priming of tumor antigen-specific T cells by dendritic cells sensitized with diverse anti-MICA opsonized tumor cells. Proc. Natl Acad. Sci. USA102(18), 6461–6466 (2005).
   PubMed Web of Science ®Google Scholar
• Harbers SO, Crocker A, Catalano G et al. Antibody-enhanced cross-presentation of self antigen breaks T cell tolerance. J. Clin. Invest.117(5), 1361–1369 (2007).
   PubMedGoogle Scholar
• Kalergis AM, Ravetch JV. Inducing tumor immunity through the selective engagement of activating Fcgamma receptors on dendritic cells. J. Exp. Med.195(12), 1653–1659 (2002).
   PubMed Web of Science ®Google Scholar
• Desai DD, Harbers SO, Flores M et al. Fc gamma receptor IIB on dendritic cells enforces peripheral tolerance by inhibiting effector T cell responses. J. Immunol.178(10), 6217–6226 (2007).
   PubMed Web of Science ®Google Scholar
• Flores M, Desai DD, Downie M et al. Dominant expression of the inhibitory FcgammaRIIB prevents antigen presentation by murine plasmacytoid dendritic cells. J. Immunol.183(11), 7129–7139 (2009).
   PubMedGoogle Scholar
• Wykes M, Pombo A, Jenkins C, Macpherson GG. Dendritic cells interact directly with naive B lymphocytes to transfer antigen and initiate class switching in a primary T-dependent response. J. Immunol.161(3), 1313–1319 (1998).
   PubMed Web of Science ®Google Scholar
• Dubois B, Bridon JM, Fayette J et al. Dendritic cells directly modulate B cell growth and differentiation. J. Leukoc. Biol.66(2), 224–230 (1999).
   PubMedGoogle Scholar
• Dubois B, Barthelemy C, Durand I, Liu YJ, Caux C, Briere F. Toward a role of dendritic cells in the germinal center reaction: triggering of B cell proliferation and isotype switching. J. Immunol.162(6), 3428–3436 (1999).
   PubMed Web of Science ®Google Scholar
• Johansson B, Ingvarsson S, Bjorck P, Borrebaeck CA. Human interdigitating dendritic cells induce isotype switching and IL-13-dependent IgM production in CD40-activated naive B cells. J. Immunol.164(4), 1847–1854 (2000).
   PubMedGoogle Scholar
• Bergtold A, Desai DD, Gavhane A, Clynes R. Cell surface recycling of internalized antigen permits dendritic cell priming of B cells. Immunity23(5), 503–514 (2005).
   PubMedGoogle Scholar
• Tackenberg B, Jelcic I, Baerenwaldt A et al. Impaired inhibitory Fc gamma receptor IIB expression on B cells in chronic inflammatory demyelinating polyneuropathy. Proc. Natl Acad. Sci. USA106(12), 4788–4792 (2009).
   PubMed Web of Science ®Google Scholar
• Tackenberg B, Nimmerjahn F, Lunemann JD. Mechanisms of IVIG efficacy in chronic inflammatory demyelinating polyneuropathy. J. Clin. Immunol.30Suppl 1. 65–69 (2010).
   Google Scholar
• Mackay M, Stanevsky A, Wang T et al. Selective dysregulation of the FcgammaIIB receptor on memory B cells in SLE. J. Exp. Med.203(9), 2157–2164 (2006).
   PubMed Web of Science ®Google Scholar
• Su K, Yang H, Li X et al. Expression profile of FcgammaRIIb on leukocytes and its dysregulation in systemic lupus erythematosus. J. Immunol.178(5), 3272–3280 (2007).
   PubMed Web of Science ®Google Scholar
• Blank MC, Stefanescu RN, Masuda E et al. Decreased transcription of the human fcgr2b gene mediated by the -343 G/C promoter polymorphism and association with systemic lupus erythematosus. Hum. Genet.117(2–3), 220–227 (2005).
   PubMedGoogle Scholar
• Su K, Li X, Edberg JC, Wu J, Ferguson P, Kimberly RP. A promoter haplotype of the immunoreceptor tyrosine-based inhibitory motif-bearing FcgammaRIIb alters receptor expression and associates with autoimmunity. II. Differential binding of GATA4 and Yin-Yang1 transcription factors and correlated receptor expression and function. J. Immunol.172(11), 7192–7199 (2004).
   PubMed Web of Science ®Google Scholar
• Su K, Wu J, Edberg JC et al. A promoter haplotype of the immunoreceptor tyrosine-based inhibitory motif-bearing FcgammaRIIb alters receptor expression and associates with autoimmunity. I. Regulatory fcgr2b polymorphisms and their association with systemic lupus erythematosus. J. Immunol.172(11), 7186–7191 (2004).
   PubMed Web of Science ®Google Scholar
• Kyogoku C, Dijstelbloem HM, Tsuchiya N et al. Fcgamma receptor gene polymorphisms in Japanese patients with systemic lupus erythematosus: contribution of fcgr2b to genetic susceptibility. Arthritis Rheum.46(5), 1242–1254 (2002).
   PubMed Web of Science ®Google Scholar
• Siriboonrit U, Tsuchiya N, Sirikong M et al. Association of Fcgamma receptor IIb and IIIb polymorphisms with susceptibility to systemic lupus erythematosus in Thais. Tissue Antigens61(5), 374–383 (2003).
   PubMed Web of Science ®Google Scholar
• Chu ZT, Tsuchiya N, Kyogoku C et al. Association of Fcgamma receptor IIb polymorphism with susceptibility to systemic lupus erythematosus in Chinese: a common susceptibility gene in the Asian populations. Tissue Antigens63(1), 21–27 (2004).
   PubMed Web of Science ®Google Scholar
• Niederer HA, Willcocks LC, Rayner TF et al. Copy number, linkage disequilibrium and disease association in the fcgr locus. Hum. Mol. Genet.19(16), 3282–3294 (2010).
   PubMed Web of Science ®Google Scholar
• Floto RA, Clatworthy MR, Heilbronn KR et al. Loss of function of a lupus-associated FcgammaRIIb polymorphism through exclusion from lipid rafts. Nat. Med.11(10), 1056–1058 (2005).
   PubMed Web of Science ®Google Scholar
• Kono H, Kyogoku C, Suzuki T et al. FcgammaRIIB Ile232Thr transmembrane polymorphism associated with human systemic lupus erythematosus decreases affinity to lipid rafts and attenuates inhibitory effects on B cell receptor signaling. Hum. Mol. Genet.14(19), 2881–2892 (2005).
   PubMed Web of Science ®Google Scholar
• Smith KG, Clatworthy MR. FcgammaRIIB in autoimmunity and infection: evolutionary and therapeutic implications. Nat. Rev. Immunol.10(5), 328–343 (2010).
   PubMedGoogle Scholar
• Li X, Wu J, Carter RH et al. A novel polymorphism in the Fcgamma receptor IIB (CD32B) transmembrane region alters receptor signaling. Arthritis Rheum.48(11), 3242–3252 (2003).
   PubMed Web of Science ®Google Scholar
• Legrand N, Ploss A, Balling R et al. Humanized mice for modeling human infectious disease: challenges, progress, and outlook. Cell Host Microbe6(1), 5–9 (2009).
   PubMed Web of Science ®Google Scholar
• Macchiarini F, Manz MG, Palucka AK, Shultz LD. Humanized mice: are we there yet? J. Exp. Med.202(10), 1307–1311 (2005).
   PubMedGoogle Scholar
• Negi VS, Elluru S, Siberil S et al. Intravenous immunoglobulin: an update on the clinical use and mechanisms of action. J. Clin. Immunol.27(3), 233–245 (2007).
   PubMed Web of Science ®Google Scholar
• Crow AR, Brinc D, Lazarus AH. New insight into the mechanism of action of IVIg: the role of dendritic cells. J. Thromb. Haemost.7(Suppl 1.), 245–248 (2009).
   PubMedGoogle Scholar
• Nimmerjahn F, Ravetch JV. Anti-inflammatory actions of intravenous immunoglobulin. Annu. Rev. Immunol.26, 513–533 (2008).
   PubMed Web of Science ®Google Scholar
• Bruhns P, Samuelsson A, Pollard JW, Ravetch JV. Colony-stimulating factor-1-dependent macrophages are responsible for IVIG protection in antibody-induced autoimmune disease. Immunity18(4), 573–581 (2003).
   PubMed Web of Science ®Google Scholar
• Kaneko Y, Nimmerjahn F, Madaio MP, Ravetch JV. Pathology and protection in nephrotoxic nephritis is determined by selective engagement of specific Fc receptors. J. Exp. Med.203(3), 789–797 (2006).
   PubMed Web of Science ®Google Scholar
• Kaneko Y, Nimmerjahn F, Ravetch JV. Anti-inflammatory activity of immunoglobulin G resulting from Fc sialylation. Science313(5787), 670–673 (2006).
   PubMed Web of Science ®Google Scholar
• Samuelsson A, Towers TL, Ravetch JV. Anti-inflammatory activity of IVIG mediated through the inhibitory Fc receptor. Science291(5503), 484–486 (2001).
   PubMed Web of Science ®Google Scholar
• Crow AR, Song S, Freedman J et al. IVIg-mediated amelioration of murine ITP via FcgammaRIIB is independent of SHIP1, SHP-1, and Btk activity. Blood102(2), 558–560 (2003).
   PubMed Web of Science ®Google Scholar
• Anthony RM, Kobayashi T, Wermeling F, Ravetch JV. Intravenous gammaglobulin suppresses inflammation through a novel T(h)2 pathway. Nature475(7354), 110–113 (2011).
   PubMed Web of Science ®Google Scholar
• Scallon BJ, Tam SH, Mccarthy SG, Cai AN, Raju TS. Higher levels of sialylated Fc glycans in immunoglobulin G molecules can adversely impact functionality. Mol. Immunol.44(7), 1524–1534 (2007).
   PubMed Web of Science ®Google Scholar
• Anthony RM, Wermeling F, Karlsson MC, Ravetch JV. Identification of a receptor required for the anti-inflammatory activity of IVIG. Proc. Natl Acad. Sci. USA105(50), 19571–19578 (2008).
   PubMed Web of Science ®Google Scholar
• Nikolova KA, Tchorbanov AI, Djoumerska-Alexieva IK, Nikolova M, Vassilev TL. Intravenous immunoglobulin up-regulates the expression of the inhibitory FcgammaIIB receptor on B cells. Immunol. Cell Biol.87(7), 529–533 (2009).
   PubMed Web of Science ®Google Scholar
• Li F, Ravetch JV. Inhibitory Fcgamma receptor engagement drives adjuvant and anti-tumor activities of agonistic CD40 antibodies. Science333(6045), 1030–1034 (2011).
   PubMed Web of Science ®Google Scholar
• Wilson NS, Yang B, Yang A et al. An Fcgamma receptor-dependent mechanism drives antibody-mediated target-receptor signaling in cancer cells. Cancer Cell19(1), 101–113 (2011).
   PubMed Web of Science ®Google Scholar
• White AL, Chan HT, Roghanian A et al. Interaction with FcgammaRIIB is critical for the agonistic activity of anti-CD40 monoclonal antibody. J. Immunol.187(4), 1754–1763 (2011).
   PubMed Web of Science ®Google Scholar
• Xu Y, Szalai AJ, Zhou T et al. Fc gamma Rs modulate cytotoxicity of anti-Fas antibodies: implications for agonistic antibody-based therapeutics. J. Immunol.171(2), 562–568 (2003).
   PubMed Web of Science ®Google Scholar